Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Midori Morita"'
Autor:
Saya Matsumoto, Ryo Tsunashima, Sae Kitano, Akira Watanabe, Chikage Kato, Midori Morita, Koichi Sakaguchi, Balázs Győrffy, Yasuto Naoi
Publikováno v:
Cancer Treatment and Research Communications, Vol 36, Iss , Pp 100711- (2023)
Background: The prognosis of lymphnode positive breast cancer is worse than that of lymph node negative breast cancer but some cases may not require chemotherapy. We investigated the ability of the new multi-gene assays, 95GC and 155GC, to identify p
Externí odkaz:
https://doaj.org/article/aff462a08955409580b8352c278222a1
Fluorescence‐based discrimination of breast cancer cells by direct exposure to 5‐aminolevulinic acid
Autor:
Midori Morita, Hideo Tanaka, Yasuaki Kumamoto, Akihiro Nakamura, Yoshinori Harada, Takehiro Ogata, Koichi Sakaguchi, Tetsuya Taguchi, Tetsuro Takamatsu
Publikováno v:
Cancer Medicine, Vol 8, Iss 12, Pp 5524-5533 (2019)
Abstract Protoporphyrin IX‐fluorescence measurement is a powerful in situ approach for cancer detection after oral/topical administration of 5‐aminolevulinic acid. However, this approach has not been clinically established for breast cancer, prob
Externí odkaz:
https://doaj.org/article/b2847d6c8c7848dab7939615c8b780f6
Autor:
MIDORI MORITA, ASAKO OOE, WATARU ISHII, AKIRA WATANABE, CHISE MATSUI, YUKA OKUYAMA, SAE KITANO, CHIKAGE KATO, MIE ONISHI, KOICHI SAKAGUCHI, YASUTO NAOI
Publikováno v:
Anticancer Research. 43:2783-2789
Autor:
YUMIKO ISHIZUKA, YOSHIYA HORIMOTO, MIDORI MORITA, YUKINO KAWAMURA, KATSUTOSHI SEKINE, SAYAKA OBAYASHI, YUKI KOJIMA, EMI TOKUDA, TORU HIGUCHI, AKIHIKO SHIMOMURA
Publikováno v:
Cancer Diagnosis & Prognosis; Nov/Dec2023, Vol. 3 Issue 6, p678-686, 9p
Autor:
Midori Morita, Mahiro Iizuka-Ohashi, Daichi Kakibuchi, Tetsuya Taguchi, Yoshimi Ouchi, Chikage Kato, Motoki Watanabe, Fuyuki Kitano, Koichi Sakaguchi, Takumi Narita
Publikováno v:
Journal of Clinical Biochemistry and Nutrition
Cutaneous side effects are often observed in patients treated with chemotherapeutic agents, including those treated with epidermal growth factor receptor (EGFR) inhibitors. These side effects are not fatal but often require dose reduction of chemothe
Autor:
Manabu Futamura, Takahiro Nakayama, Tersuhiro Yoshinami, Chiya Oshiro, Mikiya Ishihara, Midori Morita, Akira Watanabe, Azusa Taniguchi, Masami Tsukabe, Masafumi Shimoda, Kanae Mitta, Yoko Chihara, Hiroyuki Yasojima, Yoshimi Ouchi, Yoshihisa Tokumaru, Takuma Ishihara, Norikazu Masuda
Publikováno v:
Cancer Research. 83:P5-02
(Background) Cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i) improve the prognosis of hormone receptor-positive HER2-negative breast cancer (HR+/HER2- BC) by approximately 5 years. However, some patients show resistance to CDK4/6i and have poor
Autor:
Maria, Nishimura, Midori, Morita, Yuka, Okuyama, Chise, Matsui, Akira, Watanabe, Erika, Iguchi, Mie, Oonishi, Rie, Yasuoka, Koichi, Sakaguchi, Tetsuya, Taguchi
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 49(5)
Granulocyte colony-stimulating factor(G-CSF)is useful for preventing febrile neutropenia induced by chemotherapy. Recently, some cases of aortitis have been reported following administration of G-CSF. Here, we present a case of aortitis induced by pe
Autor:
Midori Morita, Akihiko Shimomura, Emi Tokuda, Yoshiya Horimoto, Yukino Kawamura, Yumiko Ishizuka, Katsutoshi Sekine, Sayaka Obayashi, Yuki Kojima, Yukari Uemura, Toru Higuchi
Publikováno v:
Breast cancer (Tokyo, Japan). 29(3)
Background Due to the lack of clinical trials on the efficacy of chemotherapy in older patients, an optimal treatment strategy has not been developed. We investigated whether adjuvant chemotherapy could improve the survival of older patients with bre
Autor:
Satomi Tomida, Dayan B. Goodenowe, Ritei Uehara, Koichi Sakaguchi, Tetsuya Taguchi, Midori Morita, Etsuko Ozaki, Nagato Kuriyama, Teruhide Koyama, Yasuyo Yamazaki
Publikováno v:
Cancers
Volume 13
Issue 16
Cancers, Vol 13, Iss 4170, p 4170 (2021)
Volume 13
Issue 16
Cancers, Vol 13, Iss 4170, p 4170 (2021)
The polyunsaturated fatty acid (PUFA) elongase, ELOVL5, is upregulated in breast cancer (BC) vs. adjacent normal tissue. We performed a comprehensive lipid metabolomic analysis of serum using high-resolution accurate mass spectrometry from two case-c
Fluorescence‐based discrimination of breast cancer cells by direct exposure to 5‐aminolevulinic acid
Autor:
Takehiro Ogata, Tetsuya Taguchi, Yasuaki Kumamoto, Tetsuro Takamatsu, Midori Morita, Yoshinori Harada, Hideo Tanaka, Akihiro Nakamura, Koichi Sakaguchi
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 8, Iss 12, Pp 5524-5533 (2019)
Cancer Medicine, Vol 8, Iss 12, Pp 5524-5533 (2019)
Protoporphyrin IX‐fluorescence measurement is a powerful in situ approach for cancer detection after oral/topical administration of 5‐aminolevulinic acid. However, this approach has not been clinically established for breast cancer, probably due